Vertex Pharmaceuticals (NASDAQ:VRTX) Research Coverage Started at Scotiabank
Scotiabank initiated coverage on shares of Vertex Pharmaceuticals (NASDAQ:VRTX – Free Report) in a research note released on Wednesday, MarketBeat reports. The firm issued a sector perform rating and a $480.00 price objective on the pharmaceutical company’s stock. A number of other research analysts also recently issued reports on the stock. Royal Bank of Canada […]
20 Oct 06:01 · The Markets Daily